{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:07:40Z","timestamp":1780553260521,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015317","name":"Translational Research Institute, University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA166060-01A1"],"award-info":[{"award-number":["R01 CA166060-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014751","name":"Tropical Resources Institute","doi-asserted-by":"publisher","award":["1 UL1TR000039"],"award-info":[{"award-number":["1 UL1TR000039"]}],"id":[{"id":"10.13039\/100014751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.bone.2014.01.015","type":"journal-article","created":{"date-parts":[[2014,1,29]],"date-time":"2014-01-29T08:05:19Z","timestamp":1390982719000},"page":"176-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans"],"prefix":"10.1016","volume":"61","author":[{"given":"Archana","family":"Kamalakar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali S.","family":"Bendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity L.","family":"Washam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan W.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Carver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Bracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen S.","family":"Akel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron G.","family":"Margulies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances L.","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey O.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parshawn","family":"Lahiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline J.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E.","family":"Leitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Gaddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J.","family":"Suva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2014.01.015_bb0005","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.ejca.2009.04.022","article-title":"Adjuvant bisphosphonates in breast cancer: are we witnessing the emergence of a new therapeutic strategy?","volume":"45","author":"Coleman","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0010","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11914-010-0012-5","article-title":"Adjuvant bisphosphonates in breast cancer: the ABCSG-12 study","volume":"8","author":"Suva","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.bone.2014.01.015_bb0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1677\/ERC-09-0012","article-title":"Mechanisms of bone metastases of breast cancer","volume":"16","author":"Suva","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2010.227","article-title":"Bone metastasis: mechanisms and therapeutic opportunities","volume":"7","author":"Suva","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.bone.2014.01.015_bb0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0035","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2014.01.015_bb0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0002-9440(10)64005-9","article-title":"A potential role for interleukin 8 in the metastatic phenotype of breast carcinoma cells","volume":"158","author":"De Larco","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2014.01.015_bb0045","first-page":"5571","article-title":"Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo","volume":"62","author":"Bendre","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S8756-3282(03)00086-3","article-title":"Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease","volume":"33","author":"Bendre","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.01.015_bb0055","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1158\/0008-5472.CAN-06-1210","article-title":"Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0060","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/0008-5472.CAN-08-2741","article-title":"Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature","volume":"69","author":"Charafe-Jauffret","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0065","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cell.2009.11.025","article-title":"Tumor self-seeding by circulating cancer cells","volume":"139","author":"Kim","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bone.2014.01.015_bb0070","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1172\/JCI39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Ginestier","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.01.015_bb0075","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1158\/0008-5472.CAN-11-0156","article-title":"IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells","volume":"71","author":"Fernando","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0080","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1078-0432.CCR-12-3450","article-title":"Breast cancer stem cells: we've got them surrounded","volume":"19","author":"Korkaya","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0085","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1158\/1078-0432.CCR-04-0812","article-title":"Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival","volume":"10","author":"Benoy","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0090","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1078-0432.CCR-12-1063","article-title":"Targeting CXCR1\/2 significantly reduces breast cancer stem cell activity and increases the efficacy of inhibiting HER2 via HER2-dependent and -independent mechanisms","volume":"19","author":"Singh","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1359\/jbmr.080703","article-title":"Establishing a reference interval for bone turnover markers in 637 healthy, young, premenopausal women from the United Kingdom, France, Belgium, and the United States","volume":"24","author":"Glover","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0100","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1158\/0008-5472.CAN-05-2630","article-title":"Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway","volume":"65","author":"Bendre","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0105","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1158\/0008-5472.CAN-05-0749","article-title":"Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases","volume":"65","author":"Kelly","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0110","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1074\/jbc.270.16.9121","article-title":"Interleukin-8 receptor beta. The role of the carboxyl terminus in signal transduction","volume":"270","author":"Ben-Baruch","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2014.01.015_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/cyto.1996.0133","article-title":"IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B","volume":"9","author":"Ben-Baruch","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2014.01.015_bb0120","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI117450","article-title":"Long-term impaired neutrophil migration in mice overexpressing human interleukin-8","volume":"94","author":"Simonet","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.01.015_bb0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2005.06.022","article-title":"Transgenic overexpression of interleukin-8 in mouse liver protects against galactosamine\/endotoxin toxicity","volume":"44","author":"Hanson","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bone.2014.01.015_bb0130","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0135","doi-asserted-by":"crossref","first-page":"e42967","DOI":"10.1371\/journal.pone.0042967","article-title":"Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment","volume":"7","author":"Fowler","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.01.015_bb0140","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/ajpath.2008.070417","article-title":"Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease","volume":"172","author":"Suva","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bone.2014.01.015_bb0145","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1210\/en.2006-0848","article-title":"Inhibin A is an endocrine stimulator of bone mass and strength","volume":"148","author":"Perrien","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2014.01.015_bb0150","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-12-1318-T","article-title":"Identification of PTHrP (12\u201348) as a plasma biomarker associated with breast cancer bone metastasis","volume":"22","author":"Washam","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bone.2014.01.015_bb0155","doi-asserted-by":"crossref","first-page":"11791","DOI":"10.1073\/pnas.0402090101","article-title":"Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury","volume":"101","author":"Bertini","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bone.2014.01.015_bb0160","first-page":"2655","article-title":"Combined administration of antibodies to human interleukin 8 and epidermal growth factor receptor results in increased antimetastatic effects on human breast carcinoma xenografts","volume":"8","author":"Salcedo","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0165","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1158\/0008-5472.CAN-2506-2","article-title":"Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells","volume":"64","author":"Aalinkeel","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0170","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1038\/sj.bjc.6602227","article-title":"Interleukin-8\/CXCL8 is a growth factor for human lung cancer cells","volume":"91","author":"Zhu","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cncr.27669","article-title":"Clinical implications and diagnostic usefulness of correlation between soluble major histocompatibility complex class I chain-related molecule a and protumorigenic cytokines in pancreatic ductal adenocarcinoma","volume":"119","author":"Chung","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0180","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cyto.2012.04.036","article-title":"The expression of interleukin-8 and interleukin-8 receptors in endometrial carcinoma","volume":"59","author":"Ewington","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.bone.2014.01.015_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.oraloncology.2012.01.006","article-title":"The role of IL-8 in the SDF-1alpha\/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma","volume":"48","author":"Li","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bone.2014.01.015_bb0190","first-page":"302","article-title":"Value of interleukin-8 determination in diagnosis of benign and malignant breast tumor","volume":"13","author":"Zakrzewska","year":"2002","journal-title":"Pol Merkur Lekarski"},{"key":"10.1016\/j.bone.2014.01.015_bb0195","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/153303460400300501","article-title":"Serum interleukin-8 is elevated in men with prostate cancer and bone metastases","volume":"3","author":"Lehrer","year":"2004","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.bone.2014.01.015_bb0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archotol.130.8.929","article-title":"Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma","volume":"130","author":"St John","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bone.2014.01.015_bb0205","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.01.015_bb0210","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1172\/JCI57099","article-title":"Breast cancer stem cells, cytokine networks, and the tumor microenvironment","volume":"121","author":"Korkaya","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bone.2014.01.015_bb0215","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ijc.11724","article-title":"Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays","volume":"109","author":"Lin","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bone.2014.01.015_bb0220","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/0008-5472.CAN-05-2666","article-title":"Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines","volume":"66","author":"Moscova","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bone.2014.01.015_bb0225","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1002\/eji.1830191228","article-title":"Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine","volume":"19","author":"Van Damme","year":"1989","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.bone.2014.01.015_bb0230","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO- alpha and leaves RANTES and MCP-2 intact","volume":"96","author":"Van den Steen","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bone.2014.01.015_bb0235","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1046\/j.1432-1033.2003.03760.x","article-title":"Gelatinase B\/MMP-9 and neutrophil collagenase\/MMP-8 process the chemokines human GCP-2\/CXCL6, ENA-78\/CXCL5 and mouse GCP-2\/LIX and modulate their physiological activities","volume":"270","author":"Van Den Steen","year":"2003","journal-title":"Eur J Biochem"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T03:38:23Z","timestamp":1762659503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":47,"alternative-id":["S8756328214000179"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.01.015","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}